Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel FeCl3-catalyzed route offers high yields and scalability for drug discovery, reducing costs in API manufacturing significantly.
Novel Pd-catalyzed method for trifluoromethyl chromone quinoline. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediates.
Patent CN112239456B reveals a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolone intermediates, offering significant cost reduction in API manufacturing.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113683595B reveals sulfur-promoted synthesis offering cost reduction and scalable production for high-purity pharmaceutical intermediates globally.
Novel palladium-catalyzed carbonylation for pyrone derivatives. Cost-effective, scalable process for pharmaceutical intermediates supply chain optimization.
Patent CN112898192B details a safe carbonylation route for N-acyl indoles using solid CO sources, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN113683595B reveals sulfur-promoted synthesis eliminating explosive peroxides. Enables cost reduction and reliable supply chain for high-purity pharmaceutical intermediates.
Novel silver oxide promoted synthesis route for high purity pharmaceutical intermediates offering significant cost reduction and supply chain reliability for global buyers.
Patent CN112538054B details a novel Pd-catalyzed carbonylation route for 1,2,4-triazol-3-ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108690007B reveals a green C-H coupling method using ionic liquids. This technology offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN108558927B details a novel Pd-catalyzed asymmetric alkenylation for silicon stereocenters. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN113004181B reveals a novel Pd-catalyzed carbonylation method using sulfonyl chlorides, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112480015B details a Pd-catalyzed one-pot synthesis. Offers cost reduction in API manufacturing and high-purity pharmaceutical intermediates with scalable protocols.
Patent CN108314642B reveals a green triethylamine-based route for 2-methylpyridines. Offers cost reduction and scalable pharma intermediate manufacturing without heavy metals.
Patent CN114539198B reveals a novel palladium-catalyzed route for chroman amides, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel NHC-catalyzed route for trifluoromethyl homoisoflavones offers mild conditions and high yields, ensuring reliable supply chain stability.
Patent CN116655529A reveals a nickel-catalyzed route for 3-aryl quinolines, offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.